Volume 21 (2022)
Volume 20 (2021)
Volume 19 (2020)
Volume 18 (2019)
Volume 17 (2018)
Volume 16 (2017)
Volume 15 (2016)
Volume 14 (2015)
Volume 13 (2014)
Volume 12 (2013)
Volume 11 (2012)
Volume 10 (2011)
Evaluation of rivaroxaban versus warfarin for the treatment of cerebral vein thrombosis: A case-control blinded study

Fariborz Khorvash; Mohammad Javad Farajpour-Khanaposhtani; Helia Hemasian; Mohammad Saadatnia

Volume 20, Issue 3 , July 2021, , Pages 125-130

https://doi.org/10.18502/cjn.v20i3.7687

Abstract
  Background: Anticoagulation therapy following cerebral vein thrombosis (CVT) can improve mortality and morbidity. Vitamin K antagonists are currently the routine oral anticoagulant used for CVT; while by introduction of rivaroxaban, a direct factor Xa inhibitor, the attentions have been deviated toward ...  Read More

Amyotrophic lateral sclerosis with laboratory abnormalities of uncertain significance: A brief review.

Majid Ghasemi; Farzad Fatehi; Bahador Asadi; Fariborz Khorvash

Volume 11, Issue 1 , March 2012, , Pages 25-27

Abstract
  Amyotrophic lateral sclerosis (ALS), the most common form of motor neuron disease, is a progressive and devastating disease involving both lower and upper motor neurons, typically following a relentless progression towards death. Therefore, all efforts must be made by the clinician to exclude alternative ...  Read More